The Science of
Cellular Regeneration

Discover how we reverse biological aging without genetic modification

Our Technology

Prometheus Cells:
Your Body's Time Machine

Our proprietary autologous rejuvenated fibroblast (auto-rFib) technology transforms your own aged cells into their younger, more functional state. Unlike genetic modification or stem cell therapies, we work with your body's natural cellular mechanisms to restore youthful function.

Zero Genetic Modification

Pure epigenetic reprogramming preserves your genetic integrity while reversing cellular aging markers

90%+ Success Rate

Industry-leading efficiency in converting aged cells to their rejuvenated state

15-Day Transformation

Complete cellular rejuvenation achieved in just two weeks of specialized treatment

Our Advantages

Why Celljevity?

Key advantages of our autologous cell rejuvenation technology

01

No Genetic Modification

Pure epigenetic reprogramming preserves your DNA integrity while reversing aging markers

100%DNA Preserved
02

Proven Clinical Results

Demonstrated efficacy across multiple age-related conditions with peer-reviewed outcomes

89%Success Rate
03

Rapid Treatment

Complete cellular rejuvenation achieved in just 15 days of specialized treatment

15Days to Results
04

GMP Certified Process

State-of-the-art facilities ensure the highest quality and safety standards

FDA Compliant
05

Personalized Medicine

Using your own cells eliminates rejection risk and ensures perfect compatibility

0%Rejection Risk
06

Scientific Excellence

Backed by publications in Nature, Science, and Cell journals

Peer Reviewed

Treatment Journey

The Rejuvenation Process

From collection to treatment in five precise steps

Tissue Collection
01

Tissue Collection

A small 1cm² skin biopsy is collected from behind the ear under local anesthesia

Cell Isolation
02

Cell Isolation

Fibroblasts are isolated and expanded in our GMP-certified laboratories

Rejuvenation Protocol
03

Rejuvenation Protocol

Proprietary 15-day treatment reverses cellular aging markers to embryonic levels

Quality Validation
04

Quality Validation

Single-cell RNA sequencing confirms successful rejuvenation before release

Therapeutic Delivery
05

Therapeutic Delivery

20 billion rejuvenated cells delivered via targeted injection or IV infusion

Clinical Validation

Evidence-Based Results

Peer-reviewed outcomes from our comprehensive clinical trials

Clinical Success Rates by Condition

Alzheimer's Disease89%Autoimmune Disorders90%Osteoarthritis67%Rheumatoid Arthritis78%Spinal Cord Injury45%Age-related Decline85%20%40%60%80%100%
Clinical Success Rates
Patient Improvement Rate

Key Clinical Outcomes

Alzheimer's Disease

37 patients

Cognitive function preserved or improved in 89% of patients

24-month follow-up

Autoimmune Disorders

56 patients

90% experienced significant symptom relief

18-month study

Osteoarthritis

80 patients

67% showed measurable joint improvement

12-month trial

Global Collaboration

Research Partners

Working with world-class institutions to advance regenerative medicine

UCLA Medical Center logo

UCLA Medical Center

Los Angeles, CA

Tongji University School of Medicine logo

Tongji University School of Medicine

Shanghai, China

Shanghai Institute for Advanced Immunochemical Studies logo

Shanghai Institute for Advanced Immunochemical Studies

Shanghai, China

Kunming Medical University logo

Kunming Medical University

Kunming, China

Shanghai Academy of Science & Technology logo

Shanghai Academy of Science & Technology

Shanghai, China

Innovation Roadmap

The Future of
Regenerative Medicine

Pioneering the next generation of cellular therapies

Spinal Cord Repair

Early studies show promise in using rejuvenated cells to repair spinal cord injuries, potentially restoring function to paralyzed patients.

Research Progress45%

Organ Regeneration

We're developing protocols to regenerate damaged organ tissue, starting with liver and kidney applications for chronic disease patients.

Research Progress30%

AI-Powered Personalization

Machine learning algorithms will optimize treatment protocols for individual patients based on their unique cellular signatures.

Research Progress60%

Ready to Learn More?

Whether you're a researcher interested in collaboration or a patient seeking treatment, we're here to answer your questions.